← Leaderboards
Ruiyun Zhang
Industrial Science &Technology Network
$2,958,256
Attributed
$2,958,256
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $736.4K · FY2006–10$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$2,958,256 · 2
By mechanism
R44$2,799,415 · 1
R43$158,841 · 1
Top collaborators
No co-investigators on record.
Most similar at Industrial Science &Technology Network
Same institution · by research overlap
- Yoon-Jeong J Park$363,349
Others in their field
Top investigators on “Heparin”
- Thomas L Ortel · Duke University$23,256,763
- Mortimer Poncz · University Of Pennsylvania$22,311,527
- Umesh Ramanlal Desai · Versiti Blood Health, Inc.$11,929,621
- Douglas Brock Cines · Duke University$11,304,101
- Patricio Ernesto Ray · Children'S National Medical Center$11,000,597
- Erik Ian Tucker · Aronora, Inc.$10,952,616
Research focus
HeparinProtaminesMolecular WeightArginineAnticoagulantsAdverse ReactionsAmino AcidsCardiacBlood Glucose RegulationBlood CirculationBioreactorsAnticoagulationAnaphylaxisBlood VesselsBaseAdsorptionAwardBedsBiodistributionAcuteAntibodiesBlood GlucoseAutacoidsAnimal Testing
Grant awards (6)
Effective and Non-Toxic Antagonist to Heparin and LMWH$249,500
R44 · FY2010 · HL · contact PI
Effective and Non-Toxic Antagonist to Heparin and LMWH$715,015
R44 · FY2008 · HL · contact PI
Effective and Non-Toxic Antagonist to Heparin and LMWH$715,015
R44 · FY2007 · HL · contact PI
Effective and Non-Toxic Antagonist to Heparin and LMWH$736,368
R44 · FY2006 · HL · contact PI
Silica-Chitosan Nanocomposite for Treating Peptic Ulcer$158,841
R43 · FY2004 · DK
Effective and Non-toxic Antagonist to Heparin and LMWH$383,517
R44 · FY2003 · HL